Hexima has executed its first commercial licence for the Multi-Gene Expression Vehicle (MGEV) technology. This is an exciting milestone for the company. Long term collaborator DuPont Pioneer has exercised its commercial option under an existing research licence to develop products via this technology.
The MGEV is a platform protein stacking technology with broad application across multiple crops and traits. Pioneer has secured a non-exclusive licence to develop insect control products intended for commercialization using the MGEV technology. Financial details have not been released.